Correlation Between Pharma-Bio Serv and Solitron Devices

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharma-Bio Serv and Solitron Devices at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharma-Bio Serv and Solitron Devices into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharma Bio Serv and Solitron Devices, you can compare the effects of market volatilities on Pharma-Bio Serv and Solitron Devices and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharma-Bio Serv with a short position of Solitron Devices. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharma-Bio Serv and Solitron Devices.

Diversification Opportunities for Pharma-Bio Serv and Solitron Devices

0.12
  Correlation Coefficient

Average diversification

The 3 months correlation between Pharma-Bio and Solitron is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Pharma Bio Serv and Solitron Devices in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Solitron Devices and Pharma-Bio Serv is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharma Bio Serv are associated (or correlated) with Solitron Devices. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Solitron Devices has no effect on the direction of Pharma-Bio Serv i.e., Pharma-Bio Serv and Solitron Devices go up and down completely randomly.

Pair Corralation between Pharma-Bio Serv and Solitron Devices

Given the investment horizon of 90 days Pharma Bio Serv is expected to generate 2.4 times more return on investment than Solitron Devices. However, Pharma-Bio Serv is 2.4 times more volatile than Solitron Devices. It trades about 0.02 of its potential returns per unit of risk. Solitron Devices is currently generating about 0.05 per unit of risk. If you would invest  91.00  in Pharma Bio Serv on November 2, 2024 and sell it today you would lose (29.00) from holding Pharma Bio Serv or give up 31.87% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy93.52%
ValuesDaily Returns

Pharma Bio Serv  vs.  Solitron Devices

 Performance 
       Timeline  
Pharma Bio Serv 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Pharma Bio Serv are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Pharma-Bio Serv showed solid returns over the last few months and may actually be approaching a breakup point.
Solitron Devices 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Solitron Devices are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong fundamental indicators, Solitron Devices is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pharma-Bio Serv and Solitron Devices Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharma-Bio Serv and Solitron Devices

The main advantage of trading using opposite Pharma-Bio Serv and Solitron Devices positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharma-Bio Serv position performs unexpectedly, Solitron Devices can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Solitron Devices will offset losses from the drop in Solitron Devices' long position.
The idea behind Pharma Bio Serv and Solitron Devices pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.